drugset / Trial / NCT05397886

Comparison of Remimazolam With Flumazenil vs. Propofol During RFCA for Atrial Fibrillation

NCT05397886

Completed 54 enrolled Seoul National University Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

This prospective randomized trial aims to compare recovery time from discontinuation of remimazolam followed by flumazenil administration vs. propofol total intravenous anesthesia as the main general anesthetics during radiofrequency catheter ablation treatment of atrial fibrillation.

Timeline

Start
2022-08-02
Primary completion
2023-04-25
Completion
2023-04-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Flumazenil Small molecule
Comparator Propofol Small molecule Intravenous
Subject Remimazolam Small molecule

Indications

No indication recorded.